Market Cap (In KRW)
79.25 Billion
Revenue (In KRW)
166.77 Billion
Net Income (In KRW)
5.72 Billion
Avg. Volume
199.6 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3970.0-6850.0
- PE
- -
- EPS
- -
- Beta Value
- 0.453
- ISIN
- KR7004720009
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Lee Seung-Yeol
- Employee Count
- -
- Website
- https://www.wooridulpharm.com
- Ipo Date
- 2000-01-04
- Details
- PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It offers prescription drugs, OTC drugs, health food, and cosmetics. It offers its products in the form of tablet, hard capsule, granule and ointment, syrups, and suspension forms. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1961 and is headquartered in Hwaseong, South Korea.
More Stocks
-
CNUTF
-
8362The Fukui Bank, Ltd.
8362
-
LCE
-
IXAQIX Acquisition Corp.
IXAQ
-
ETTETT Limited
ETT
-
118000Wooridul Huebrain Limited
118000
-
DS
-
GGBXFGreen Growth Brands Inc.
GGBXF